Skip to main content

Table 1 Characteristics of participants by lifetime diagnosis

From: Sleep spindles in people with schizophrenia, schizoaffective disorders or bipolar disorders: a pilot study in a general population-based cohort

  

Lifetime diagnosis

 

ALL

SZ

SAD

SAM

BP-I

BP-II

CTL

χ2/F

p-value

N

1037

7

12

4

17

9

988

  

Socio-demographic factors

 Age (yrs), mean (sd)

59.8 (11.3)

63.2 (12.6)

58.2 (12.4)

54.2 (6.7)

57.0 (11.0)

57.1 (9.9)

59.9 (11.3)

F5 = 0.7

0.624

 Males, %

58.3

71.4

41.7

100.0

70.6

55.6

58.1

χ25 = 5.8

0.324

Somatic characteristics

 BMI (kg/m2), mean (sd)

25.7 (4.0)

26.1 (7.5)

25.1 (4.3)

28.4 (3.6)

26.4 (4.2)

24.7 (4.7)

25.6 (4.0)

F5 = 0.7

0.642

Sleep characteristics

 TST (min), mean (sd)

394.4 (70.1)

373.1 (127.9)

386.4 (78.6)

328.4 (46.9)

398.2 (97.5)

404.1 (72.1)

394.8 (69.0)

F5 = 0.9

0.468

 N2 (%), mean (sd)

46.7 (10.6)

45.4 (12.9)

41.6 (9.5)

43.1 (12.1)

44.6 (12.2)

45.6 (9.3)

46.9 (10.5)

F5 = 0.9

0.508

 AHI, mean (sd)

16.7 (16.9)

36.8 (47.4)

8.8 (6.7)

8.6 (3.7)

14.4 (8.9)

15.0 (12.0)

16.8 (16.7)

F5 = 2.8

0.016

Behavioral characteristics

 Current smokers, %

15.6

14.3

33.3

50.0

47.1

11.1

14.8

χ25 = 19.9

0.001

Medication

 Any medicationa, %

6.1

42.9

25.0

25.0

35.3

0.0

5.1

χ25 = 5.8

< 0.001

  1. SZ Schizophrenia, SAD Schizoaffective disorder - depressive type, SAM Schizoaffective disorder - bipolar type, BP-I Bipolar type I disorder, BP-II Bipolar type II disorder, CTL Comparison participants, yrs years, min minutes, BMI Body mass index, sd standard deviation, TST Total sleep time, N2% of NREM-stage 2, AHI Apnea hypopnea index
  2. aMedication including hypnotics (ATC code: N05CF), benzodiazepines or derivates (N05BA, N05CD, N03AE), antidepressants (N06A) and neuroleptics (N05A)